Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2021

Nov 16, 2021

SELL
$1.44 - $2.73 $64,080 - $121,485
-44,500 Reduced 72.24%
17,100 $31,000
Q2 2021

Aug 16, 2021

SELL
$2.63 - $3.67 $67,854 - $94,686
-25,800 Reduced 29.52%
61,600 $163,000
Q1 2021

May 18, 2021

BUY
$2.82 - $5.6 $246,468 - $489,439
87,400 New
87,400 $315,000

Others Institutions Holding TCRT

About Alaunos Therapeutics, Inc.


  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $443M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.